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Edited by Gianni CesareniAbstract Phenotypic changes in injured livers involve complex
network of genes whose interplays may lead to ﬁbrosis and cir-
rhosis, a major risk of hepatocellular carcinoma. Gene expres-
sion proﬁles in ﬁbrotic livers were analyzed by using cDNA
microarray, hierarchical clustering and gene ontology. Analyses
of a major cluster of upregulated genes in cirrhosis identiﬁed a
new set of genes involved in DNA repair and damage. The upreg-
ulation of DNA repair genes was conﬁrmed by real-time quanti-
tative polymerase chain reaction and associated with
necroinﬂammatory activity (P < 0.001). Increased DNA repair
activity in cirrhosis with inﬂammatory activity may reﬂect in-
creased DNA damages as a consequence of chronic liver injury.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Most chronic liver diseases may lead to cirrhosis, which is
characterized by extensive connective tissue deposition, regen-
eration, vascular disorders and hepatocyte necrosis. It is the
main risk factor for the development of hepatocellular carci-
noma (HCC), cirrhotic macronodules being suggested as po-
tential premalignant lesions [1–3]. Thus, it is hypothesized
that the transformation of hepatocytes towards a neoplastic
phenotype results from a cascade of molecular events leading
to irreversible DNA damages [4]. Recently, large overall
screening of gene expression by cDNA array analyses has iden-
tiﬁed upregulated genes involved in inﬂammation, ﬁbrosis and
regeneration, and a molecular signature including genes in-
volved in several molecular pathways was proposed for cirrho-q This work was supported by the Institut National de la Sante´ et de la
Recherche Me´dicale, the Association pour la Recherche contre le
Cancer and the Region Bretagne (PRIR No. 139). Pierre Zindy was a
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doi:10.1016/j.febslet.2004.09.092sis associated with HCC [5]. The present study was designed to
investigate gene networks involved in the response to chronic
injury. Instead of analyzing this process with a gene-by-gene
approach, we chose to combine cDNA microarray and a bio-
informatics tool that carries out simple datamining using gene
ontology (GO). Diﬀerentially expressed genes in microarray
experiments evidenced a new cluster of genes associated with
DNA repair, including mechanistically distinct repair systems,
i.e., nucleotide excision repair, homologous recombination and
post-replicative repair. In addition, our data show an associa-
tion between upregulated DNA repair genes and cirrhosis
activity assessed by piecemeal necrosis, lobular necrosis and
portal inﬂammation.2. Materials and methods
2.1. Patients and tissue samples
Matching non-tumor livers were obtained from patients undergoing
surgical hepatectomy or liver transplantation for hepatocellular carci-
noma. Controls were histologically normal liver samples, obtained
from the non-tumoral parts of livers complicated with metastatic tu-
mor. The histologic stage of ﬁbrosis and the intensity of necroinﬂam-
matory lesions were graded according to the METAVIR score [6]:
AO = no activity, A1 = mild, A2 = moderate, A3 = severe and F0,
no ﬁbrosis; F1, portal ﬁbrosis without septa; F2, portal ﬁbrosis with
rare septa; F3 numerous septa without cirrhosis and F4 cirrhosis. Clin-
ical characteristics of patients and histologic annotations are shown in
Table 1. Access to this material was in agreement with French laws and
satisﬁed the requirements of the local Ethics Committee.
2.2. Microarray hybridizations
Fourteen samples including three F1, three F2, three F3 and ﬁve F4
stage were analyzed. Microarray hybridization (Atlas Human Cancer
1.2 Array, Clontech, Palo Alto, CA) was performed as indicated by
the manufacturer and each sample was compared with a pool of mRNA
extracted from control livers (n = 14). Both spot radioactive quantiﬁca-
tion of intensity and global normalization using the sum method were
realized using the Atlas Image 2.01 software (Clontech). The ratio of
each ﬁbrotic sample versus the control pool sample intensity was then
calculated. The reproducibility of themicroarray data was evaluated be-
tween ﬁve independent hybridizations of the pool control and the corre-
lation coeﬃcients varied from 0.64 to 0.81 (P < 0.05).
2.3. Cluster, statistical and ontology analyses
Before analysis, gene expression data were log2-transformed and
centralized. The cluster analysis was performed with average uncen-
tered linkage clustering by using Cluster TreeView software (http://
rana.Stanford.EDU/software). To select signiﬁcant genes, we used a
two-class unpaired t test with permutation using statistical toolblished by Elsevier B.V. All rights reserved.
Fig. 1. Hierarchical clustering of 14 patients with liver ﬁbrosis and
selected 697 genes analyzed using Cluster and TreeView software
(http://rana.Stanford.EDU/software/). (A) Red and green colors illus-
trate over- and under-expressed genes in ﬁbrotic tissues, respectively.
Black and gray represent unchanged or absent gene expression. (B)
The tree shows ﬁve branches (I–V) indicating the order in which
patients were grouped based on similarities in their pattern of gene
expression. (C) Black bar beside the gene dendogram corresponds to
the cluster of upregulated genes in cirrhoses.
Table 1
Clinical characteristics of patients. (\: samples analyzed by macro-
array)
Case Age Gender Alcohol HCV HBV Metavir score
1 53 M    A0F1
2 76 M +   A0F1
3 61 M +   A0F1
4 72 M    A1F1
\ 5 61 M +   A0F1
\ 6 75 M    A0F1
7 72 M    A0F1
8 76 M    A1F1
\ 9 73 M +   A0F1
10 73 M +   A3F2
11 75 M    A1F2
\ 12 72 M  + + A0F2
13 62 M +   A0F2
\ 14 56 M    A0F2
\ 15 68 M    A1F2
16 64 M +   A0F2
17 81 M    A1F2
18 68 M +   A0F3
19 66 M +   A1F3
\ 20 74 M +   A0F3
\ 21 66 M    A0F3
22 64 M  +  A2F3
23 67 M + +  A1F3
\ 24 63 M    A0F3
\ 25 74 M    A0F4
26 61 M +  + A0F4
27 54 M    A0F4
\ 28 52 M +   A0F4
\ 29 50 M +   A0F4
30 60 M   + A3F4
31 52 M  + + A2F4
32 67 M +   A1F4
33 57 M + +  A2F4
34 65 M   + A2F4
35 63 M +   A2F4
\ 36 37 M   + A3F4
37 66 M   + A2F4
38 59 M +   A2F4
\ 39 56 F    A1F4
96 P. Zindy et al. / FEBS Letters 579 (2005) 95–99SAM (http://www-stat.stanford.edu/~tibs/SAM/). In order to iden-
tify the biological processes involved by modulated gene, we per-
formed a GO analysis by using FatiGO (http://
fatigo.bioinfo.cnio.es), a web interface which carries out simple dat-
amining using GO for DNA microarray data (http://www.geneon-
tology.org/).
2.4. Real-time quantitative PCR (RT-qPCR)
Real-time quantitative PCR was performed on RNA extracted from
tissue samples with the ﬂuorescent dye SYBR Green methodology
using the qPCRe Core Kit for Sybre Green I from Eurogentec (Ser-
aing, Belgium) and the ABI Prism 7000 (Perkin–Elmer, Foster City,
CA). Primer pairs were: P53, sense: 5 0-tgcaataggtgtgcgtcagaa-30, anti-
sense: 5 0-tgcaataggtgtgcgtcagaa-30, ATM, sense: 5 0-tgacgttacatgagc-
cagca-30, antisense: 5 0-tgacgttacatgagccagca-30; RAD23A, sense: 5 0-
ccaggagaaccctcagcttt-30, antisense: 5 0-tcagcatctggatgaactgc-30;
UBE2A, sense: 5 0-ggagcagaggaatggaaaca-3 0, antisense: 5 0-agggcagcact-
gatccttta-30; ERCC1, sense: 5 0-tagcggaggctgaggaaca-30, antisense: 5 0-
ggcgacgtaattcccgact-30; XPA, sense: 5 0-gcaccactgtaccccaggtt-3 0, anti-
sense: 5 0-ttccccactgtttccacca-3 0; XRCC1, sense: 5 0-cagccctacagcaagg-
actc-3 0, antisense: 5 0-gcctctgcctcatctttgtc-30.
2.5. Western blot analyses
Frozen serial sections from tissue blocks were scrapped and proteins
solubilized in sample buﬀer and subjected to SDS–PAGE. The blots
were incubated with either anti-XPA or anti-ERCC1 antibodies (Santa
Cruz Biotechnology, Santa Cruz, CA) and revealed with a peroxidase-
conjugated anti-rabbit immunoglobulins (Pierce).2.6. Immunohistochemistry
Five-micrometer-thick frozen sections were ﬁxed in 4% paraformal-
dehyde buﬀered in PBS (pH 7.4), blocked in 2% BSA–PBS (w/v), incu-
bated with antibodies at 4 C overnight and subsequently incubated
with peroxidase conjugated goat anti-rabbit IgG (Sigma, St. Quentin,
France). Speciﬁc antibodies were omitted in controls and all sections
were counterstained with hematoxylin.
2.7. P53 gene sequencing
DNA was ampliﬁed by PCR between exon 4 and exon 8 (sense: 5 0-
tactcccctgccctcaacaa-30, antisense: 5 0-cagtgctcgcttagtgct-3 0) and direct
DNA sequencing was performed with a BigDye sequencing kit (Ap-
plied Biosystem, CA). Electrophoresis and sequence analysis were per-
formed with ABI PRISM 310.3. Results and discussion
Analyses of membranes by the Atlas Image 2.01 software
demonstrated that 697 plotted genes showed a signiﬁcant sig-
nal (>5000) in at least one of the experiments, indicating a cor-
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cDNA. To further clarify the relationships between the ﬁbrotic
stages and genes analyzed, we performed hierarchical cluster-
ing of the 14 ﬁbrotic/cirrhotic livers and genes (Fig. 1A). The
resulting dendogram showed ﬁve main cluster branches (I–V)
(Fig. 1B), the length of branches reﬂecting the relatedness of
samples. The two nearest clusters, including branches I and
II, contained the ﬁve cirrhotic samples and the three otherTable 2
Major gene networks of signiﬁcantly overexpressed genes in cirrhosis (two-c
Symbol Full name
Inﬂammatory response
CXCL12 Chemokine (C–X–C motif) ligand 12
BTG2 BTG family, member 2
AIF1 Allograft inﬂammatory factor 1
CSF1R Colony stimulating factor 1 receptor
VEGF Vascular endothelial growth factor
IL1A Interleukin 1, a
IL1B Interleukin 1, b
TYROBP TYRO protein tyrosine kinase binding protein
Fibrogenesis
COL6A1 Collagen, type VI, a1
COL6A2 Collagen, type VI, a2
COL6A3 Collagen, type VI, a3
COL11A1 Collagen, type XI, a1
MMP12 Matrix metalloproteinase 12
HSPG2 Heparan sulfate proteoglycan 2 (perlecan)
DCN Decorin
TIMP1 Tissue inhibitor of metalloproteinase 1
COPEB Core promoter element binding protein, ZF9
Cell proliferation
NME2 Non-metastatic cells 2, protein (NM23B) expr
RFC4 Replication factor C (activator 1)
PCNA Proliferating cell nuclear antigen
RFC3 Replication factor C (activator 1) 3.38 kDa
CDK6 Cyclin-dependent kinase 6
PDGFRA Platelet-derived growth factor receptor, a poly
PDGFB Platelet-derived growth factor b polypeptide
MYC c-myc oncogen
Cell death
RAF1 c-raf proto-oncogen
TNFRSF6 Tumor necrosis factor receptor superfamily, 6
CASP4 Caspase 4, apoptosis-related cysteine protease
TRADD TNFRSF1A-associated via death domain
BAX BCL2-associated X protein
BCL2 B-cell CLL/lymphoma 2
MCL1 Myeloid cell leukemia sequence 1 (BCL2-relat
CASP1 Caspase 1, apoptosis-related cysteine protease
CASP7 Caspase 7, apoptosis-related cysteine protease
CASP8 Caspase 8, apoptosis-related cysteine protease
Response to DNA damage
CDC34 Cell division cycle 34
CHES1 Checkpoint suppressor 1
UBE2A Ubiquitin-conjugating enzyme E2A (RAD6 ho
UBL1 Ubiquitin-like 1 (sentrin)
RAD23A RAD23 homolog A (S. cerevisiae)
RAD50 RAD50 homolog (S. cerevisiae)
HMGB2 High-mobility group box 2
ERCC3 Excision repair cross-complementing
DDIT3 DNA-damage-inducible transcript 3
DDB2 Damage-speciﬁc DNA binding protein 2, 48 k
ERCC1 Excision repair cross-complementing
XPA Xeroderma pigmentosum, complementation gr
XRCC1 X-ray repair cross-complementing protein 1
ATM Ataxia telangiectasia mutatedbranches clustered ﬁbrotic samples according to their stage
(branche III for F1, branche IV for F3 and branche V for
F2). Diﬀerences in gene proﬁles between the ﬁve cirrhotic sam-
ples appeared associated with the necroinﬂammatory activity,
since the two cirrhotic livers in branche II showed an enhanced
activity (A1 and A3) compared with the three other cirrhotic
livers included in branche I (A0). When analyzing the cluster-
ing of genes based on their relative expression, a major clusterlass t test with SAM; FDR = 10%)
ID Mean ratio
Hs.237356 2.0
Hs.75462 6.8
Hs.76364 3.6
Hs.174142 2.8
Hs.73793 11.1
Hs.1722 1.9
Hs.126256 2.5
Hs.9963 3.4
Hs.108885 8.0
Hs.420269 2.8
Hs.233240 15.5
Hs.439168 4.8
Hs.1695 3.0
Hs.211573 6.8
Hs.433989 5.1
Hs.5831 3.1
Hs.285313 7.0
essed in Hs.433416 27.4
Hs.35120 4.5
Hs.78996 4.2
Hs.115474 5.8
Hs.38481 4.7
peptide Hs.74615 8.6
Hs.1976 7.5
Hs.202453 9.6
Hs.257266 2.8
Hs.82359 2.7
Hs.74122 2.4
Hs.89862 6.0
Hs.159428 20.4
Hs.79241 3.1
ed) Hs.86386 4.9
Hs.2490 9.0
Hs.9216 2.7
Hs.381231 6.2
Hs.423615 5.3
Hs.211773 2.6
molog) Hs.379466 38.2
Hs.81424 10.2
Hs.180455 6.7
Hs.41587 2.1
Hs.80684 6.2
Hs.77929 6.9
Hs.400353 33.7
Da Hs.77602 8.0
Hs.59544 4.4
oup A Hs.288867 5.0
Hs.98493 1.8
Hs.526394 4.7
98 P. Zindy et al. / FEBS Letters 579 (2005) 95–99of upregulated genes in cirrhotic livers was identiﬁed (Fig. 1C).
Since hierarchical clustering analysis showed distinct gene
expression pattern between cirrhosis and ﬁbrosis, we selected
genes whose expression is signiﬁcantly altered in cirrhosis by
using a two-class t test with permutation using statistical tool
SAM. GO analysis of these genes revealed gene networks asso-
ciated with molecular pathways previously described in
chronic liver injuries, including inﬂammatory response, ﬁbro-
genesis, cell proliferation, and cell death (Table 2). Thus, the
increase in chemokine CXCL12 expression (stromal cell-
derived factor 1), which activates leukocytes in response to a
proinﬂammatory stimulus, supported the recent report of
CXCL12 induction in biliary epithelial cells of inﬂammatory
liver diseases [7]; in addition, TYROBP (DAP12), a transmem-
brane adapter molecule for tyrosine kinase receptor, has been
involved in liver hepatic granulomatous inﬂammation [8].
Fibrogenesis hallmarks included collagen VI, perlecan, deco-
rin, TIMP1 and COPEB (ZF9), a DNA-binding protein CPBP
which was previously described as an important signal in hepa-
tic stellate cells activation by transactivating promoters driving
ﬁbrogenesis, including ﬁbrillar collagens [9]. Cellular prolifera-
tion was characterized by an upregulation of PCNA (prolifer-
ating cell nuclear antigen) and genes involved in apoptosis
included the tumor necrosis factor receptor superfamily, i.e.,2
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Fig. 2. RT-qPCR analysis of DNA repair gene expression in 14
cirrhosis. (A) Data are plotted as medians (square) and 25–75th
percentiles (box). (B) Spearman rank order correlations between
quantiﬁed mRNA levels. (C) Association of DNA repair gene
expression with (black bars) or without (white bars) necroinﬂamma-
tory activity in cirrhoses (*P < 0.05; **P < 0.01; and ***P < 0.001).TRADD, TNFRSF6/FAS, the caspase family (CASP1, 4, 7
and 8) and genes associated with the mitochondrial pathway,
i.e., BAX, BCL2 and MCL1.
An unexpected ﬁnding was the upregulation of genes in-
volved in DNA repair, including mechanistically distinct repair
systems [10,11], i.e., nucleotide-excision repair: ERCC3,
RAD23A, XPA and ERCC1 related to lesions arising from
exogenous sources, base-excision repair: XRCC1, homologous
recombination: ATM and RAD50 which repair double strands
breaks, and the post-replicative repair: UBE2A and UBL1. In
addition, we showed upregulation of CDC34 and ches1, twoFig. 3. ERCC1 and XPA in cirrhotic livers. (A) Western blotting of
protein extracted from liver sections. (B) Immunochemical staining of
ERCC1 (a) and XPA (b) vascular endothelial cells (v) and biliary
epithelial cells (bc) are labeled. ERCC1 and XPA staining is weak or
absent in control livers (c and d, respectively). Original magniﬁcation
(a and b, ·100; c and d, ·50). Immunoperoxidase was counterstained
with hematoxylin.
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cess in cell division for maintenance of genomic stability which
induces DNA strand breaks-inducible cell cycle arrests at G1
and G2 [12]. Increased expression of XPA, ERCC1, ATM,
XRCC1, RAD23A and UBE2A was conﬁrmed by RT-qPCR
on a large set of cirrhotic tissues (n = 14) (Fig. 2A). Further-
more, all DNA repair gene mRNA levels were highly
correlated (Fig. 2B). Although deﬁcient repair of DNA lesion
O6-methylguanine in cirrhosis was recently reported [13] and a
399Gln polymorphism in XRCC1 gene was found associated
with a high risk of liver cirrhosis [14], DNA repair activity in
chronic liver diseases is poorly documented. In the present
study, overexpression of several DNA repair associated genes
might reﬂect DNA repair perturbation in cirrhosis.
Because p53 tumor suppressor activity has been suggested to
trigger DNA repair in response to various types of stress, we
investigated p53 gene expression. Steady-state p53 mRNA lev-
els were signiﬁcantly increased in cirrhotic livers and Spearman
correlation analyses showed strong associations between p53
and DNA repair genes expression, namely ATM (R = 0.93),
RAD23A (R = 0.79), UBE2A (R = 0.89), ERCC1 (R = 0.73),
XPA (R = 0.89) and XRCC1 (R = 0.84) (Fig. 2B). Since con-
troversial data about increased expression and mutations of
p53 gene were reported in cirrhosis, p53 gene sequence was
investigated in the 14 cirrhotic livers. Double sequencing, per-
formed for exons 4–8 with oligonucleotides designed for DNA
ampliﬁcation, revealed no missense mutation in the studied
samples (data not shown).
To clarify the upregulation of DNA repair gene network, we
tested a possible association of gene expression with clinical
parameters or pathological features of the cirrhotic livers.
RT-qPCR data were correlated with sex, age, alcohol, virus
and necroinﬂammatory activity. Spearman rank order correla-
tion studies showed association between the necroinﬂamma-
tory activity and the steady-state mRNA levels of DNA
repair genes: ATM (R = 0.65, P < 0.05), RAD23A (R = 0.57,
P < 0.05), UBE2A (R = 0.64, P < 0.05) and XPA (R = 0.66,
P < 0.01). In active cirrhosis (n = 9) versus quiescent cirrhoses
(n = 5), all mRNA levels for DNA repair genes were statisti-
cally increased (Fig. 2C).
We further validated the association between DNA repair
gene expression and activity in cirrhosis by examining, at
the protein level, two selected genes involved in the repair
of covalent bulky helix-distorting DNA lesions: XPA initiates
DNA repair by stabilizing the proteins responsible for DNA
incision [15] and ERCC1 plays a direct role in incision byendonuclease activity [16]. Western blots analysis showed that
the amounts of both proteins were induced in cirrhotic livers
(Fig. 3A). Interestingly, immunostaining for ERCC1 and
XPA was predominantly associated with endothelial cells of
vessels and biliary epithelial cells (Fig. 3B), thus indicating
that non-parenchymal cells, in addition to hepatocytes
(Langouet et al., unpublished data), activate DNA repair
pathways in cirrhosis.
In conclusion, our data show an upregulation of DNA re-
pair genes in cirrhosis associated with necroinﬂammatory
activity, suggesting enhanced DNA repair activity to restore
higher damages induced by exogenous and endogenous
DNA reactive agents.
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